Trazodone is not classified as a sedative, but it has strong sedating effects, especially at low doses. It belongs to a class of antidepressants called serotonin antagonist and reuptake inhibitors (SARIs), and the FDA approved it in 1982 specifically for major depressive disorder. Despite that, its use as a sleep aid has surpassed its use as an antidepressant, making it one of the most widely prescribed medications for insomnia in the United States.
Why Trazodone Causes Sedation
Trazodone’s drowsiness isn’t an accident of its chemistry. At low doses, the drug blocks three types of receptors in the brain that play direct roles in keeping you awake: serotonin receptors involved in arousal, histamine receptors (the same ones targeted by over-the-counter sleep aids like diphenhydramine), and adrenaline-related receptors that maintain alertness. This triple blockade is what makes trazodone so reliably sedating, even though it was designed as an antidepressant.
The sedation is dose-dependent in an unusual way. Lower doses tend to produce more noticeable drowsiness relative to their other effects, while the antidepressant properties require higher doses. This is why doctors typically prescribe it at lower amounts for sleep and at higher amounts for depression.
How It’s Used for Sleep
Trazodone’s use for insomnia is entirely off-label. The FDA has only approved it for major depressive disorder, and there is no formal insomnia indication on the label. That hasn’t stopped it from becoming a go-to prescription for sleep problems, largely because doctors view it as carrying less risk of dependence than traditional sleep medications like benzodiazepines or Z-drugs such as zolpidem.
The appeal is straightforward: patients who struggle with sleep get a medication that reliably makes them drowsy, without the same habit-forming profile associated with conventional sedatives. For people who also have underlying depression or anxiety, trazodone can address both issues in a single prescription.
What Sleep Medicine Guidelines Say
Despite its popularity, major medical organizations have actually recommended against using trazodone for insomnia. The American Academy of Sleep Medicine published clinical practice guidelines advising clinicians not to use trazodone for sleep onset or sleep maintenance problems, citing the absence of robust efficacy studies and some evidence of harm. The American College of Physicians reached the same conclusion in its 2016 insomnia treatment guidelines. The U.S. Department of Veterans Affairs and Department of Defense also advised against it, stating that the low-quality evidence supporting its effectiveness was outweighed by its side effect profile. A 2018 Cochrane Library review, considered the gold standard for evidence synthesis, found insufficient evidence to recommend trazodone for insomnia.
This creates an unusual situation: one of the most commonly prescribed sleep aids in the country lacks strong clinical evidence backing that specific use. Many doctors continue prescribing it based on clinical experience and the perception that it’s safer than alternatives, but the gap between its popularity and its evidence base is real.
Common Side Effects
The same sedating properties that make trazodone useful for sleep also drive its most frequent side effects. Daytime drowsiness, dizziness, and a general feeling of unusual tiredness or weakness are among the most commonly reported problems. Many people experience lightheadedness when standing up quickly from a sitting or lying position, a drop in blood pressure that can be disorienting. Blurred vision, confusion, and sweating also appear on the list of common effects.
For men, there is a rare but serious risk of priapism, a prolonged and painful erection that requires emergency medical treatment. This is uncommon, but it’s serious enough that it appears as a specific precaution on the drug’s labeling.
Trazodone and Alcohol
Combining trazodone with alcohol intensifies sedation, which is dangerous on its own. But the interaction runs deeper than simple drowsiness. In a clinical trial of 173 people going through alcohol detoxification, those given trazodone actually experienced less improvement in days abstinent compared to placebo over three months. The effect persisted for three months after the medication was stopped.
Researchers believe this may have a biological explanation. Trazodone breaks down into a metabolite that has been linked to increased alcohol craving in studies. This pattern isn’t unique to trazodone. Several serotonin-targeting antidepressants have shown similar paradoxical effects, with some trials reporting increased use of alcohol, tobacco, cocaine, and other substances in certain patients. For anyone with a history of alcohol problems, this interaction is worth taking seriously.
How It Compares to Traditional Sedatives
True sedatives, like benzodiazepines and Z-drugs, work by enhancing the brain’s primary calming neurotransmitter (GABA). They are potent, fast-acting, and carry a well-documented risk of physical dependence, tolerance, and withdrawal symptoms. Trazodone works through entirely different brain pathways, and it does not carry the same dependence risk. You won’t develop the kind of escalating tolerance that leads people to need higher and higher doses of a benzodiazepine to fall asleep.
That said, stopping trazodone abruptly after regular use can still cause discontinuation symptoms, as with most antidepressants. The distinction matters: dependence on traditional sedatives involves cravings and physiological need, while antidepressant discontinuation is more of a temporary adjustment period as the brain recalibrates. For many prescribers, this lower risk profile is the main reason trazodone gets chosen over medications that are formally approved for insomnia.